Chromatin & Cancer Biologists at Columbia university

New York, NY
Joined October 2017
Please spread the word and register. Great event for sharing science and building collaboration for NYC epigenetic labs!
Registration - NYC Chromatin Club - July 21, 2026 - mailchi.mp/nycchromatinclub.…
6
8
1,465
Here we go! Excited to share our latest collaborative work with @MichaelMShen and @califano_lab. We uncovered that NSD2-catalyzed H3K36me2, a histone mark dearest to our lab, is critical for lineage plasticity and resistance to anti-androgen in prostate cancer.
2
1
6
896
While there is still a lot to learn about the underlying mechanism, these findings suggest the therapeutic potential of combining NSD2 inhibitor with AR inhibitor in treating aggressive prostate tumors. A clinical study is already ongoing: clinicaltrials.gov/study/NCT…
1
127
Further, recent work from Gozani, Mazur, Majewski and Jaremko labs demonstrates therapeutic benefit of NSD2 inhibitor in preclinical models of lung and pancreatic cancers, suggesting a broad role of H3K36me2 in cancer chromatin plasticity: nature.com/articles/s41586-0…
1
109
Symposium Registration Deadline Friday! - NYC Chromatin Club - mailchi.mp/cbee4a4e6267/regi…
3
2
5
869
Registration - NYC Chromatin Club - July 15, 2025 - mailchi.mp/c3d82b17e5c0/regi…
2
6
380
Excited to share this review on chromatin-metabolism crosstalk, lead by our star student Varun Sahu. Here, Varun summarizes the molecular principles governing metabolite-chromatin interaction & highlights emerging technologies that could advance the field. There’re lots to learn!
1
7
41
3,916
Check out this important work - congrats to KJ, Victoria and the team!
This Post is from an account that no longer exists. Learn more
2
691
Congrats again to @KristjanGretars @Xagbomson Susan Gloor, Dan Weinberg, @KJArmache @GCloner @epicypher and everyone involved! Thanks to the reviewers and editor @ScienceAdvances for improving our manuscript.
2
2
1,053
Lastly, shoutout to two other papers that characterize the interaction between DNMT3A and H2AK119Ub nucleosome. nature.com/articles/s41467-0…  by Jikui Song and Greg Wang groups. biorxiv.org/content/10.1101/…  by @mdrwilson group.
1
276
Lu Lab_Columbia retweeted
What's new and what's next in cancer epigenetics research? Join us for the 2024 VAI Epigenetics Symposium. Our allstar speaker lineup will highlight the latest advances with a focus on mechanisms and therapeutic applications. Registration closes tomorrow! vai.org/event/vai-epigenetic…
9
2
22
4,542
Please see tweetorial below for the latest from the lab led by @KristjanGretars. In collaboration with @GCloner @KJArmache @Xagbomson, this work reveals molecular details of DNMT3A targeting to polycomb CGIs and its implication for cancer-associated DNA hypermethylation.
1
4
27
3,945
It also implies that perturbing the interaction between DNMT3A-H2AK119Ub could be a potential strategy to prevent or reverse DNA hypermethylation in cancer.
1
235
Please see tweetorial above for more details! As always, we welcome your feedback and suggestions.
194
Lu Lab_Columbia retweeted
Free Hybrid World Class Symposium- Featuring Academic and Pharma/Biotech Leaders! Register asap. >400 registered and counting. #Epigenetics #3DGenome #Chromatin @GAlmouzni @KharasLab @METorresPadilla @ranigeorgelab @LuLaboratory @job_dekker @DaiichiSankyoUS @AstraZeneca @CeiFccc
8
15
2,381